Beneficial metabolic impact of the novel immunosuppressant rapamycin in chronic canine islet autograft recipients. [electronic resource]
- Transplantation proceedings Dec 1995
- 3213 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0041-1345
Animals Cyclosporine--adverse effects Dogs Immunosuppressive Agents--adverse effects Insulin--blood Islets of Langerhans Transplantation--adverse effects Polyenes--adverse effects Sirolimus Time Factors Transplantation, Autologous